|Market Size in 2022||Market Forecast in 2030||CAGR (in %)||Base Year|
|USD 5.55 Billion||USD 8.75 Billion||8.37%||2022|
Cell Culture Market
The global cell culture market size was evaluated at $5.55 billion in 2022 and is slated to hit $8.75 billion by the end of 2030 with a CAGR of nearly 8.37% between 2023 and 2030.
Cell culture is defined as a process of cell removal from animal as well as plant sources under controlled conditions. Moreover, this artificial environment includes pH, humidity, ideal temperature, and gases that play a major role in cell multiplication. Furthermore, removing of cells from the tissues is possible only with the help of mechanical and enzymatic procedures before cell cultivation.
Technological innovations in biopharma domain will drive the growth of the market globally in next eight years
Technological breakthroughs in proteomic gene expression and large-scale production of biopharmaceuticals & vaccines will bolster the demand for 3D cell culture systems, thereby driving the global cell culture market trends. Government support for cell-based research activities and the development of cell-based vaccines will steer the expansion of the global market. In addition to this, a prominent surge in the demand for monoclonal antibodies along with the use of single-use systems and a high focus on precision medicine will steer the expansion of the global market in the years ahead.
Apart from this, the rise in the presence of contract manufacturing and research organizations in countries such as the U.S. and Canada will steer the expansion of the market across the globe. Increase in the research on stem cells will proliferate the size of the global market in the years ahead. New product launches and strategic alliances will favorably impact the expansion of the global market in the years ahead. For instance, in the second half of 2022, Cytiva, a key life sciences firm based in the U.S., acquired Cevec Pharmaceuticals GmbH. The strategic move will boost the position of Cytiva in the biomanufacturing solutions portfolio globally.
Low use of new techniques facilitating high-density cell culture research can halt the global industry expansion
Less use of new technologies that can enable high-density cell cultures will put brakes on the expansion of the global cell culture industry.
Increase in the research & development activities related to cell culture techniques use will open new growth opportunities for the global market
Rise in the research activities on cell culture development in APAC countries is likely to offer new growth avenues for the global cell culture market in the coming years.
Government restrictions on use of plastic consumables can challenge the global industry surge by 2030
Cell culture depends massively on plastic consumables and this can lead to the production of huge amounts of plastic waste every year, thereby proving to be a huge challenge for the global cell culture industry expansion.
The global cell culture market is sectored into product, application, and region.
In product terms, the global cell culture market is segregated into consumables and instruments segments. Furthermore, the consumables segment, which gathered nearly 58% of the global market revenue share in 2022, is projected to register the fastest CAGR in the upcoming years. The growth of the segment in the estimated timeline can be due to a rise in the demand for consumables in the cell culture activities. Surge in the spending on research activities related to biotechnology & biopharmaceutical business will embellish the segmental surge over the ensuing years.
Based on the application, the global cell culture industry is sectored into biopharmaceutical production, diagnostics, and cell & gene therapy segments. Moreover, the biopharmaceutical production segment, which garnered a huge chunk of the global industry revenue share in 2022, is projected to lead the global industry over the analysis timespan. The segmental expansion over the assessment timeframe can be owing to a rise in biopharmaceutical production in countries such as China. Apart from this, breakthroughs in the grafting methods and substitutes for precision medicine will culminate notably towards the segmental expansion over the forecast period.
|Report Attributes||Report Details|
|Report Name||Cell Culture Market|
|Market Size in 2022||USD 5.55 Billion|
|Market Forecast in 2030||USD 8.75 Billion|
|Growth Rate||CAGR of 8.37%|
|Number of Pages||223|
|Key Companies Covered||Corning Inc., Merck KGaA, Sartorius AG, BD, Bio-Techne, Danaher Corporation, Thermo Fisher Scientific Inc., Avantor Inc., Eppendorf SE, PromoCell GmbH, and others.|
|Segments Covered||By Product, By Application, and By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)|
|Historical Year||2017 to 2021|
|Forecast Year||2023 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
North America is anticipated to maintain global market domination over the anticipated timespan
North America, which contributed about half of the global cell culture market revenue in 2022, is likely to retain its market dominance over the projected timespan. Furthermore, the regional market growth can be due to thriving pharmaceutical and biotech industries in countries such as Canada and the U.S. Growing need for cell culture techniques in clinical applications will steer the growth of the market in the region over the coming years.
Asia-Pacific cell culture industry is set to register the fastest CAGR in the upcoming years due to a rise in healthcare spending along with a surge in awareness related to gene and cell therapies. Moreover, the region possesses a huge potential for clinical research activities, thereby boosting regional industry trends. Furthermore, large-scale acceptance of emerging therapeutics such as regenerative medicines and cancer immunotherapeutics will reinforce the growth of the industry in the Asia-Pacific zone.
Cell Culture Market: Competitive Space
The global cell culture market profiles key players such as:
Cell culture is defined as a process of cell removal from animal as well as plant sources under controlled conditions.
The global cell culture market growth can be owing to government support for cell-based research activities and the development of cell-based vaccines.
According to a study, the global cell culture industry size was $5.55 billion in 2022 and is projected to reach $8.75 billion by the end of 2030.
The global cell culture market is anticipated to record a CAGR of nearly 8.37% from 2023 to 2030.
The Asia-Pacific cell culture industry is set to register the highest CAGR over the forecasting timeline owing to a rise in healthcare spending along with a surge in awareness related to gene and cell therapies.
The global cell culture market is led by players such as Corning Inc., Merck KGaA, Sartorius AG, BD, Bio-Techne, Danaher Corporation, Thermo Fisher Scientific, Inc., Avantor Inc., Eppendorf SE, and PromoCell GmbH.
The cell culture market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.